Resonance Health

Resonance Health Market capitalization

The The market capitalization of Resonance Health (RHT.AX) as of Oct 24, 2026 is 20.42 M AUD. In the previous year, The market capitalization was 20.42 M AUD — a change of 0.00% (lower).

Market capitalization

20.42 MAUD

YoY

0.00%

Last updated:

In 2026, Resonance Health's market cap stood at 20.42 M AUD, a 0.00% increase from the 20.42 M AUD market cap in the previous year.

The Resonance Health Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2019
20.42 M AUD
Jan 1, 2020
20.42 M AUD
Jan 1, 2021
20.42 M AUD
Jan 1, 2022
20.42 M AUD
Jan 1, 2023
20.42 M AUD
Jan 1, 2024
20.42 M AUD
Jan 1, 2025
20.42 M AUD
Jan 1, 2026
20.42 M AUD
The Resonance Health Market capitalization history
YEARMarket capitalizationYoY
20.42 MAUD0.00%
20.42 MAUD0.00%
20.42 MAUD0.00%
20.42 MAUD0.00%
20.42 MAUD0.00%
20.42 MAUD0.00%
20.42 MAUD0.00%
20.42 MAUD0.00%
20.42 MAUD0.00%
20.42 MAUD0.00%
20.42 MAUD0.00%
20.42 MAUD0.00%
20.42 MAUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Resonance Health Stock analysis

What does Resonance Health do? Resonance Health Ltd is an Australian company that operates in the medical technology industry. The company's business model is to offer groundbreaking solutions for the diagnosis and treatment of liver and iron diseases. As a pioneering company in the development of methods and technologies for quantifying liver and iron concentrations, Resonance Health continually sets new standards in the industry. The company was founded in 2000 by a team of biomedicine professionals from the University of Western Australia. Over the years, the company has gained a lot of experience and constantly evolved to keep up with the progress of medical technology. The goal is to provide patients with better treatment and improved quality of life. One division of the company is the development and manufacturing of diagnostic tools for quantifying liver and iron diseases such as hepatitis, fatty liver, or hemochromatosis. The quantification method used by Resonance Health is called FerriScan. This method is non-invasive and painless, using magnetic resonance imaging (MRI) to measure the concentration of iron in the tissue. This is particularly important as a change in iron content can indicate a progressing liver disease. In addition to the FerriScan diagnostic tool, Resonance Health also offers a software package for analyzing FerriScan results, which is used by physicians and clinicians to assess disease progression. Furthermore, the company also develops solutions in the field of hemochromatosis, a genetic disorder that can lead to increased iron levels in the body. Another division of Resonance Health is the provision of research and development services to further develop and improve FerriScan and other technologies. The company collaborates with other companies, scientific institutions, and universities to advance the current developments in liver and iron diagnostics. Resonance Health has a range of products that contribute to better diagnosis and treatment of liver and iron diseases. These include FerriScan, the FerriSmart software package for precise monitoring of iron and liver health, and Hepatica, a software supporting hospitals and clinics in the diagnosis of liver diseases. The company is an innovative leader in the industry, contributing to improving the quality of life for patients. The products and services of Resonance Health have helped doctors and clinicians to effectively treat and diagnose liver and iron diseases. Additionally, the company has established a strong scientific foundation and works closely with leading institutions to continuously develop innovative solutions. Resonance Health is a company with a rich history that continues to evolve to meet the demands of the medical technology industry. The company aims to continuously improve the diagnosis and treatment of liver and iron diseases and offer better solutions. Resonance Health is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Resonance Health's Market Capitalization

Resonance Health's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Resonance Health's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Resonance Health's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Resonance Health’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Resonance Health stock

The market capitalization of Resonance Health is 20.42 M AUD in 2026.

The market capitalization of Resonance Health changed from 20.42 M AUD to 20.42 M AUD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Resonance Health since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's AUD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' AUD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Resonance Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Resonance Health

All Key Metrics — Resonance Health